Peter Maag

This profile gathers the share dealings of Peter Maag across 2 companies, led by CareDx, Inc. and Miromatrix Medical Inc. We count 53 filings; the first trade dates from 22 January 2016 and the latest from 7 July 2025.

Both buying and selling appear: 1 purchase worth €47k, against 9 sales worth €1.4M. Taken together, the sales exceed the purchases by €1.4M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 22 share grants and 20 option exercises. In 2025 alone, the filings show no purchases and 3 sales.

The record was last updated on 10 July 2025 with an open-market sale (€158k) in CareDx, Inc. The latest purchase dates back some time: it was published 1,298 days ago, on 30 March 2023. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.